A review on flavonoid-based scaffolds as multi-target-directed ligands (MTDLs) for Alzheimer's disease

European Journal of Medicinal Chemistry
Leili Jalili-BalehMehdi Khoobi

Abstract

Alzheimer's disease (AD), the most common form of dementia, is a multifactorial neurodegenerative disease. The target enzymes inhibition including cholinesterase, beta-secretase, monoamine oxidase and inhibition of amyloid-β aggregation as well as oxidative stress and metal chelation play an important role in the pathogenesis of AD. Chroman-4-one scaffold with benzo-γ-pyrone network is a privileged structure in organic synthesis and drug design. A large number of research has been carried out on modified naturally occurring chromanone scaffolds and/or synthesized new analogues, to obtain effective drugs for AD management. The present review summarizes aspects related to the multi-target-directed ligands (MTDLs) strategy in enzyme targets modulation performed with natural and synthesized chroman-4-one-based structures to look at their potential in the management of multifactorial Alzheimer's disease.

Citations

Mar 23, 2019·Journal of Biomolecular Structure & Dynamics·Rohan J MeshramRajesh N Gacche
Jun 6, 2019·Expert Opinion on Drug Discovery·Juan F GonzálezJose María Sánchez-Montero
May 29, 2019·Organic & Biomolecular Chemistry·Chaima BoureghdaBertrand Carboni
Aug 24, 2019·Archives of Toxicology·Miriama SimunkovaMarian Valko
Jun 20, 2019·Current Drug Targets·Pone Kamdem Boniface, Ferreira Igne Elizabeth
Dec 5, 2019·Current Topics in Medicinal Chemistry·Jiayang XieBing Niu
Jul 3, 2020·International Journal of Molecular Sciences·Xingyi ChengMingyao Yang
Aug 25, 2019·Antioxidants·Aimee N Winter, Paula C Bickford
Aug 31, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Luca PiemonteseMichele Solfrizzo
Feb 13, 2019·Reviews in the Neurosciences·Elnaz AmanzadehMaryam Nourbakhshnia
Jan 10, 2021·Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences·Leili Jalili-BalehMehdi Khoobi
Aug 10, 2019·Bioorganic Chemistry·Niloufar ChoubdarMehdi Khoobi
Nov 21, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Narayan D ChaurasiyaBabu L Tekwani
Mar 3, 2021·European Journal of Pharmacology·Tayebeh NooriSamira Shirooie
May 1, 2021·International Journal of Molecular Sciences·Daniela MalafaiaArtur M S Silva
May 28, 2021·Organic & Biomolecular Chemistry·Shunyao LiChunhao Yang
May 14, 2020·European Journal of Medicinal Chemistry·Nada IbrahimAbdallah Hamze

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.